Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Circulation. 2017 Feb 21; 135(8):724-735.

View in: PubMed

subject areas

Aged
Biphenyl Compounds
Body Mass Index
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Echocardiography
Female
Follow-Up Studies
Heart Failure
Heart Ventricles
Hospitalization
Humans
Incidence
Male
Natriuretic Peptide, Brain
Peptide Fragments
Proportional Hazards Models
Stroke Volume
Tetrazoles
Treatment Outcome

authors with profiles

Michael R. Zile